FKST · As filed with the SEC
Flowerkist Skin Care & Cosmetics balance sheet, by fiscal year
The statement as Flowerkist Skin Care & Cosmetics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Balance Sheets · USD
| USD | FY2021 Dec 31, 2021 | FY2020 Jul 31, 2020 | FY2019 Jul 31, 2019 | FY2018 Jul 31, 2018 | FY2017 Jul 31, 2017 | FY2016 Jul 31, 2016 | FY2015 Jul 31, 2015 | FY2014 Jan 31, 2014 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash and cash equivalents | — | — | — | — | — | 663 | — | — |
| Inventory | — | — | — | — | — | — | 54,520 | — |
| Total current assets | — | — | — | — | — | — | 68,808 | — |
| Equipment, net of accumulated depreciation of $17,036 and $3,370, respectively | — | — | — | — | — | — | 10,297 | — |
| Other Non-Operating Current Assets | — | — | — | — | — | — | 7,234 | — |
| Total Assets | — | — | — | — | — | — | 86,339 | 0 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Other Current Liabilities | — | — | — | — | — | — | — | 18,950 |
| Accounts payable and accrued liabilities | — | — | 232,227 | 232,227 | 232,227 | 232,227 | 119,672 | — |
| Accounts payable | — | 173 | — | — | — | — | — | — |
| Short-Term Debt | 1,972 | 5,259 | — | — | — | — | — | 30,307 |
| Accounts payable and accrued liabilities | — | 232,227 | — | — | — | — | — | — |
| Convertible notes | — | 602,693 | 602,693 | 602,693 | 602,693 | 602,693 | 297,966 | 38,000 |
| Short-Term Debt | — | — | — | — | — | — | — | 7,220 |
| Other Non-Operating Current Liabilities | — | — | — | — | — | — | 0 | — |
| Total current liabilities | 1,972 | 840,351 | 834,920 | 834,920 | 834,920 | 834,920 | 417,638 | — |
| Short-Term Debt | — | — | — | — | — | — | 61,002 | — |
| Long-Term Debt | — | — | — | — | — | — | 43,000 | — |
| Notes payable -long term | — | 43,000 | 43,000 | 43,000 | 43,000 | 43,000 | — | — |
| Total Liabilities | 1,972 | 883,351 | 877,920 | 877,920 | 877,920 | 877,920 | 521,640 | 94,477 |
| Stockholders' Deficit: | ||||||||
| Preferred Stock | 1,000 | — | — | — | — | — | 0 | 0 |
| Total Stockholders' Equity | 130 | 130,200 | 130,200 | 130,200 | 130,200 | 130,200 | 291,200 | 10,200 |
| Additional Paid-In Capital | 3,375,074 | 780,659 | 780,659 | 780,659 | 780,659 | 780,659 | 271,039 | 10,800 |
| Deficit accumulated during the development stage | — | — | — | — | — | — | — | (115,477) |
| Retained Earnings | (3,378,176) | (1,794,210) | (1,788,779) | (1,788,779) | (1,788,779) | (1,788,779) | (997,540) | — |
| Total stockholders' equity | (1,972) | (883,351) | (877,920) | (877,920) | (877,920) | (877,920) | (435,301) | (94,477) |
| Total liabilities and equity | — | — | — | — | — | — | 86,339 | 0 |
| Cash and Cash Equivalents | — | — | — | — | — | — | 14,288 | 0 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.